特应性皮炎诊疗指南（专科医生版本、全科医生版本和患者版本）计划书

doi:10.35541/cjd.20230248

中华皮肤科杂志 ›› 2023, Vol. 56 ›› Issue (9): 809-814.doi: 10.35541/cjd.20230248

特应性皮炎诊疗指南（专科医生版本、全科医生版本和患者版本）计划书

郭昊¹ 刘辉^2，3 张丽¹ 朱冠男⁴ 王平⁵ 姚志荣⁶ 高兴华¹ 陈耀龙^{2，5，7，8}

¹中国医科大学附属第一医院皮肤科，沈阳 110001；²中国医学科学院循证评价与指南研究创新单元，兰州大学基础医学院，兰州 730000；³兰州大学公共卫生学院，兰州 730000；⁴空军军医大学西京皮肤医院，西安 710032；⁵兰州大学基础医学院循证医学中心，兰州 730000；⁶上海交通大学医学院附属新华医院皮肤病中心，上海 200092；⁷世界卫生组织指南实施与知识转化合作中心，兰州 730000；⁸兰州大学健康数据科学研究院，兰州 730000
郭昊和刘辉对本文同等贡献

收稿日期:2023-04-28 修回日期:2023-06-19 发布日期:2023-09-07
通讯作者: 高兴华；陈耀龙；姚志荣 E-mail:gaobarry@hotmail.com; chevidence@lzu.edu.cn; zryaoxh@sina.com

Protocols for guidelines on the diagnosis and treatment of atopic dermatitis （specialist version, general practitioner version and patient version）

Guo Hao¹, Liu Hui^2,3, Zhang Li¹, Zhu Guannan⁴, Wang Ping⁵, Yao Zhirong⁶, Gao Xinghua¹, Chen Yaolong^2,5,7,8#br#

¹Department of Dermatology, The First Hospital of China Medical University, Shenyang 110001, China; ²Research Unit of Evidence-based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China; ³School of Public Health, Lanzhou University, Lanzhou 730000, China; ⁴Department of Dermatology, Xijing Hospital, Air Force Medical University, Xi′an 710032, China; ⁵Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China; ⁶Department of Dermatology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China; ⁷WHO Collaborating Center for Guideline Implementation and Knowledge Translation, Lanzhou 730000, China; ⁸Institute of Health Data Science, Lanzhou University, Lanzhou 730000, China
Guo Hao and Liu Hui contributed equally to this article

Received:2023-04-28 Revised:2023-06-19 Published:2023-09-07
Contact: Gao Xinghua; Chen Yaolong; Yao Zhirong E-mail:gaobarry@hotmail.com; chevidence@lzu.edu.cn; zryaoxh@sina.com

摘要/Abstract

摘要： 【摘要】为进一步规范医务人员对特应性皮炎的诊疗工作，同时提升患者对特应性皮炎的认识，促进医患沟通，中华医学会皮肤性病学分会和中国医师协会皮肤科医师分会联合发起特应性皮炎诊疗指南（专科医生版本、全科医生版本和患者版本）的制订工作。制订工作组参考相关制订手册和方法学文章，对3个版本的制订过程进行了规划，并拟通过本计划书，详细阐明注册、工作组组建、临床问题收集、证据检索与分级、推荐意见形成与共识等细节，以期提升指南制订的透明性。

关键词: 皮炎, 特应性, 医师, 病人, 指南, 计划书

Abstract: 【Abstract】 In order to further standardize the diagnosis and treatment of atopic dermatitis by health-care professionals, as well as to enhance the awareness of atopic dermatitis among patients and promote doctor-patient communication, Chinese Society of Dermatology and China Dermatologist Association jointly initiated the development of guidelines on the diagnosis and treatment of atopic dermatitis （specialist version, general practitioner version and patient version）. The development working group had planned the development process of the 3 versions of guidelines with reference to relevant development manuals and methodological articles. It is also intended to expound the details of registration, working group establishment, clinical question collection, evidence search and grading, recommendation formation and consensus through this protocol, aiming to enhance the transparency of guideline development.

Key words: Dermatitis, atopic, Physicians, Patients, Guideline, Protocol

郭昊刘辉张丽朱冠男王平姚志荣高兴华陈耀龙. 特应性皮炎诊疗指南（专科医生版本、全科医生版本和患者版本）计划书[J]. 中华皮肤科杂志, 2023,56(9):809-814. doi:10.35541/cjd.20230248

Guo Hao, Liu Hui, Zhang Li, Zhu Guannan, Wang Ping, Yao Zhirong, Gao Xinghua, Chen Yaolong, . Protocols for guidelines on the diagnosis and treatment of atopic dermatitis （specialist version, general practitioner version and patient version）[J]. Chinese Journal of Dermatology, 2023, 56(9): 809-814.doi:10.35541/cjd.20230248

参考文献 26

［1］	Ständer S. Atopic dermatitis［J］. N Engl J Med, 2021,384（12）:1136⁃1143. doi: 10.1056/NEJMra2023911.
［2］	Dong WL, An J, Yu M, et al. The prevalence and year lived with disability of atopic dermatitis in China: findings from the global burden of disease study 2019［J］. World Allergy Organ J, 2021,14（11）:100604. doi: 10.1016/j.waojou.2021.100604.
［3］	Cheng J, Wu JJ, Han G. Epidemiology and characterization of atopic dermatitis in East Asian populations: a systematic review［J］. Dermatol Ther （Heidelb）, 2021,11（3）:707⁃717. doi: 10. 1007/s13555⁃021⁃00516⁃w.
［4］	Laughter MR, Maymone M, Mashayekhi S, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990⁃2017［J］. Br J Dermatol, 2021,184（2）:304⁃309. doi: 10.1111/bjd.19580.
［5］	Wang X, Li LF, Zhao DY, et al. Prevalence and clinical features of atopic dermatitis in China［J］. Biomed Res Int, 2016,2016:2568301. doi: 10.1155/2016/2568301.
［6］	Guo Y, Li P, Tang J, et al. Prevalence of atopic dermatitis in Chinese children aged 1 - 7 ys［J］. Sci Rep, 2016,6:29751. doi: 10.1038/srep29751.
［7］	UpToDate. Atopic dermatitis （eczema）: pathogenesis, clinical manifestations, and diagnosis［EB/OL］.（2022⁃9⁃28）［2023⁃7⁃18］. https://www.uptodate.com/contents/atopic⁃dermatitis⁃eczema⁃ pathogenesis⁃clinical⁃manifestations⁃and⁃diagnosis.
［8］	Langan SM, Irvine AD, Weidinger S. Atopic dermatitis［J］. Lancet, 2020,396（10247）:345⁃360. doi: 10.1016/S0140⁃6736（20）31286⁃1.
［9］	World Health Organization. WHO handbook for guideline development. 2nd Ed ［M/OL］. （2014⁃12⁃18）［2023⁃07⁃18］. https://www.who.int/publications/i/item/9789241548960.
［10］	陈耀龙, 杨克虎, 王小钦, 等. 中国制订/修订临床诊疗指南的指导原则（2022版）［J］. 中华医学杂志, 2022,102（10）:697⁃703. doi: 10.3760/cma.j.cn112137⁃20211228⁃02911.
［11］	Brouwers MC, Kho ME, Browman GP, et al. AGREEⅡ: advancing guideline development, reporting and evaluation in health care［J］. CMAJ, 2010,182（18）:E839⁃842. doi: 10.1503/cmaj.090449.
［12］	杨楠, 赵巍, 潘旸, 等. 针对临床实践指南科学性、透明性和适用性的评级工具研发［J］. 中华医学杂志, 2022,102（30）:2329⁃2337. doi: 10.3760/cma.j.cn112137⁃20220219⁃00340.
［13］	Guidelines International Network （GIN）. GIN PUBLIC Toolkit: patient and public involvement in guidelines［M/OL］. ［2022⁃11⁃3］. https://g⁃i⁃n.net/wp⁃content/uploads/2021/04/GIN⁃TOOLKIT⁃COMBINED⁃FINAL⁃2015.pdf
［14］	陈耀龙, 荀杨芹, 李博, 等. 如何制订患者指南［J］. 协和医学杂志, 2020,11（4）:453⁃458. doi: 10.3969/j.issn.1674⁃9081.2020. 04.017.
［15］	陈耀龙, 马艳芳, 周奇, 等.谁应该参与临床实践指南的制订?［J］. 协和医学杂志, 2019,10（5）:524⁃530. doi: 10.3969/j.issn.1674⁃9081.2019.05.017.
［16］	Ma LL, Wang YY, Yang ZH, et al. Methodological quality （risk of bias） assessment tools for primary and secondary medical studies: what are they and which is better?［J］. Mil Med Res, 2020,7（1）:7. doi: 10.1186/s40779⁃020⁃00238⁃8.
［17］	Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations［J］. BMJ, 2008,336（7650）:924⁃926. doi: 10. 1136/bmj.39489.470347.AD.
［18］	中华医学会儿科学分会临床药理学组, 中华医学会儿科学分会呼吸学组, 刘恩梅, 等.中国儿童咳嗽指南（2021患者版）［J］.儿科药学杂志, 2021,27（S1）:17⁃22. doi: 10.13407/j.cnki.jpp.1672⁃108X.2021.S1.009.
［19］	Zhang Y, Coello PA, Brożek J, et al. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach［J］. Health Qual Life Outcomes, 2017,15（1）:52. doi: 10.1186/s12955⁃017⁃0621⁃0.
［20］	刘辉, 王华, 刘云兰, 等. 中国儿童消化道异物管理指南（患者与公众版，2022）计划书［J］. 中国实用儿科杂志, 2022,37（2）:81⁃87.
［21］	Chen Y, Yang K, Marušic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement［J］. Ann Intern Med, 2017,166（2）:128⁃132. doi: 10.7326/M16⁃1565.
［22］	王平, 周奇, 赵俊贤, 等. 临床实践指南基层版报告规范的研发［J］.中国全科医学, 2023,26（13）:1543⁃1550. doi: 10.12114/j.issn.1007⁃9572.2023.0043.
［23］	Wang X, Chen Y, Akl EA, et al. The reporting checklist for public versions of guidelines: RIGHT⁃PVG［J］. Implement Sci, 2021,16（1）:10. doi: 10.1186/s13012⁃020⁃01066⁃z.
［24］	周奇, 王小琴, 姚亮, 等. 临床实践指南更新的若干关键问题［J］. 中国循证儿科杂志, 2016,11（5）:392⁃397. doi: 10.3969/j.issn.1673⁃5501.2016.05.016.
［25］	Ghazal S, Ridha Z, D′Aguanno K, et al. Treatment guidelines for atopic dermatitis since the approval of dupilumab: a systematic review and quality appraisal using AGREE⁃Ⅱ［J］. Front Med （Lausanne）, 2022,9:821871. doi: 10.3389/fmed.2022.821871.
［26］	叶城斌, 邹颖. 不同国家及地区特应性皮炎治疗指南的比较［J］. 中国皮肤性病学杂志, 2020,34（11）:1331⁃1336,1340. doi: 10.13735/j.cjdv.1001⁃7089.202003205.

[1]	刘小扬赵琰蔡林张建中. 银屑病患者白细胞介素17拮抗剂治疗后出现特应性皮炎样皮疹4例分析与文献回顾[J]. 中华皮肤科杂志, 2023, 56(9): 845-848.
[2]	陈春里闫思聿王丹高丽华谭丽娜唐四元刘伟曾金容鲁建云. 酸化脂肪酸酯治疗特应性皮炎样模型小鼠的疗效及机制初探[J]. 中华皮肤科杂志, 2023, 56(9): 822-831.
[3]	王珊王星宇舒虹张斌石航杨欢钱秋芳马红艳梁源赵牧童申春平焦磊田晶汪洋谷盈孙婧刘盈李萍王华马琳. 克立硼罗软膏早期缓解儿童特应性皮炎临床症状及改善缓解期临床症状的多中心临床研究[J]. 中华皮肤科杂志, 2023, 56(9): 815-821.
[4]	陈耀龙刘辉姚志荣高兴华. 提升皮肤病领域指南和共识质量的策略与建议[J]. 中华皮肤科杂志, 2023, 56(9): 805-808.
[5]	申春平李萍罗晓燕梁源刘盈赵牧童王珊田晶焦磊汪洋罗珍余时娟方晓王华马琳. [开放获取] 某润肤霜联合周末外用糖皮质激素对延缓儿童特应性皮炎维持期疾病复发的随机、空白对照、多中心临床研究[J]. 中华皮肤科杂志, 2023, 56(8): 756-762.
[6]	徐西利李东宁段函王菲. 青少年及成人特应性皮炎患者血浆氨基酸代谢水平分析[J]. 中华皮肤科杂志, 2023, 56(8): 742-750.
[7]	宋志强陈奇权葛兰. 从特应性皮炎发病机制谈靶向治疗进展[J]. 中华皮肤科杂志, 2023, 56(8): 718-723.
[8]	张晓东汪蔓雅朱英杰骆天德刘小明. 荧光染色法在面部皮肤蠕形螨检查中的应用评估[J]. 中华皮肤科杂志, 2023, 56(8): 766-769.
[9]	渠莉田陈锦丛程波苏惠春. 特应性皮炎患者外周血单个核细胞转谷氨酰胺酶2的表达与相关炎症因子及疾病严重程度的相关性[J]. 中华皮肤科杂志, 2023, 56(7): 651-656.
[10]	中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2023版）[J]. 中华皮肤科杂志, 2023, 56(7): 573-625.
[11]	蒋晓妍高敏张晓艳刘宁远. 白细胞介素17和白细胞介素23拮抗剂治疗脓疱型银屑病研究进展[J]. 中华皮肤科杂志, 2023, 56(7): 689-692.
[12]	陈奇权孔敏敏杨显杰王欢李健张名望宋志强. [开放获取] 慢性诱导性荨麻疹患者168例过敏原反应性和特应性病史的临床分析[J]. 中华皮肤科杂志, 2023, 56(6): 496-503.
[13]	苏畅隋秀丽刘瑞玲曹毅群姜虹严彩蓉王惠平亓玉青. [开放获取] 奥马珠单抗治疗慢性自发性荨麻疹伴有其他过敏性疾病患者74例临床分析[J]. 中华皮肤科杂志, 2023, 56(6): 512-517.
[14]	李嘉祺叶枫鞠强. 表皮葡萄球菌共生性稳态与皮肤疾病[J]. 中华皮肤科杂志, 2023, 56(5): 459-462.
[15]	中国医师协会皮肤科医师分会中华医学会皮肤性病学分会空军军医大学西京医院中国银屑病患者饮食指南制订工作组. 中国银屑病患者饮食管理指南（2023）[J]. 中华皮肤科杂志, 2023, 56(5): 389-401.

特应性皮炎诊疗指南（专科医生版本、全科医生版本和患者版本）计划书

Protocols for guidelines on the diagnosis and treatment of atopic dermatitis （specialist version, general practitioner version and patient version）

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 26

相关文章 15

Metrics

本文评价

推荐阅读 10